Abstract
The extent to which stimulant medications impact the core symptoms of disruptive behavioral disorders (DBD) other than symptoms of ADHD is of scientific debate. Most previous studies have either not clearly provided defined outcomes or have only evaluated DBD in the context of an existing comorbid ADHD diagnosis. The goal of the current study was to determine whether patients (especially younger individuals ages 6–10 years) on stimulants have significantly better Child Behavior Checklist (CBCL) scores on questions related to conduct disorder (CD), ODD, and irritability after behavioral modification program intervention compared with those who have not received stimulant medications.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
